Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px
Organisation › Details

Grifols S.A.

Grifols is a global healthcare company with more than 75 years of legacy dedicated to improving the health and well-being of people around the world. Grifols produces essential plasma-derived medicines for patients, and provides hospitals and healthcare professionals with the tools, information and services they need to help them deliver expert medical care. Grifols’ three main divisions – Bioscience, Diagnostic and Hospital – develop, produce and market innovative products and services that are available in more than 100 countries. With a network of 250 plasma donation centers, Grifols is a leading producer of plasma-derived medicines used to treat rare, chronicand, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols offers a comprehensive portfolio of diagnostic products designed to support safety from donation through transfusion. The Hospital Division provides intravenous (IV) therapies, clinical nutrition products and hospital pharmacy systems, including systems that automate drug compounding and control drug inventory. Grifols is headquartered in Barcelona, Spain, and has 20,000 employees in 30 countries. In 2017, sales exceeded 4,300 million euros. Grifols demonstrates its strong commitment to advancing healthcare by allocating a significant portion of its annual income to research, development and innovation. The company’s class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Grifols non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the US NASDAQ via ADRs (NASDAQ:GRFS). *

 

Period Start 1940-01-01 established
  Group Grifols (Group)
Products Industry blood plasma
  Industry 2 diagnostics (medical/biological)
Person Person Grifols, Victor (Grifols 201503–201612 CEO STEPPED DOWN 12/16)
     
Region Region Barcelona
  Country Spain (España)
  City 08005 Barcelona
    Address record changed: 2009-05-15
     
Basic data Employees H: 10,001 to 50,00 (2019-06-30)
  Currency EUR
  Annual sales 4,300,000,000 (sales, consolidated (2017) 2017-12-31)
     
    * Document for �About Section�: Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona.
     
   
Record changed: 2020-03-27

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Grifols (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Made Without Love 650x80px




» top